Skip to main content
Top
Published in: Journal of Gastrointestinal Surgery 12/2012

01-12-2012 | Original Article

Surgical Management Trends for Cholangiocarcinoma in the USA 1998–2009

Authors: Jamie E. Anderson, Alan W. Hemming, David C. Chang, Mark A. Talamini, Kristin L. Mekeel

Published in: Journal of Gastrointestinal Surgery | Issue 12/2012

Login to get access

Abstract

Background

Surgical advancements have improved outcomes for cholangiocarcinoma (CCA) patients, but this expertise is not uniformly available. This research examines CCA surgical treatment patterns.

Methods

A retrospective analysis of the U.S. Nationwide Inpatient Sample from 1998–2009 identified CCA patients at high-volume (HV) versus low-volume (LV) hospitals, and teaching versus nonteaching hospitals. We performed multinomial and multivariate logistic regressions to compare differences of surgical treatment between HV vs. LV hospitals, and teaching vs. nonteaching hospitals. Liver resection (LR), pancreaticoduodenectomy, bile duct (BD) resection, and combined liver/BD resection were considered more aggressive therapy than BD stent or bypass.

Results

A total of 32,561 patients with CCA were identified. The proportion receiving surgery declined from 36 to 30 %. There was no increase in the proportion of LRs or combined liver/BD resection. Patients at HV or teaching hospitals were more likely to receive surgical treatment [odds ratio (OR), 1.3, p < 0.001; OR, 1.4, p < 0.001].

Discussion

Despite increasing evidence that surgical resection increases survival, the number of patients receiving surgery has decreased. Although combined liver/BD resection has been advocated as standard management for proximal CCA, the practice has not increased. All patients with CCA should be considered for assessment at a HV teaching hospital.
Literature
1.
2.
go back to reference Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malago M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther 2011;34(9):1063-1078.PubMedCrossRef Skipworth JR, Olde Damink SW, Imber C, Bridgewater J, Pereira SP, Malago M. Review article: surgical, neo-adjuvant and adjuvant management strategies in biliary tract cancer. Aliment Pharmacol Ther 2011;34(9):1063-1078.PubMedCrossRef
3.
go back to reference de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999;341(18):1368-1378.PubMedCrossRef de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM. Biliary tract cancers. N Engl J Med 1999;341(18):1368-1378.PubMedCrossRef
4.
go back to reference Gatto M, Alvaro D. New insights on cholangiocarcinoma. World J Gastrointest Oncol 2010;2(3):136-145.PubMedCrossRef Gatto M, Alvaro D. New insights on cholangiocarcinoma. World J Gastrointest Oncol 2010;2(3):136-145.PubMedCrossRef
5.
go back to reference Young AL, Prasad KR, Toogood GJ, Lodge JP. Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci 2010;17(4):497-504.PubMedCrossRef Young AL, Prasad KR, Toogood GJ, Lodge JP. Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds. J Hepatobiliary Pancreat Sci 2010;17(4):497-504.PubMedCrossRef
6.
go back to reference Hemming AW, Mekeel K, Khanna A, Baquerizo A, Kim RD. Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg 2011;212(4):604-13; discussion 613-6.PubMedCrossRef Hemming AW, Mekeel K, Khanna A, Baquerizo A, Kim RD. Portal vein resection in management of hilar cholangiocarcinoma. J Am Coll Surg 2011;212(4):604-13; discussion 613-6.PubMedCrossRef
7.
go back to reference Nagino M, Nimura Y, Nishio H, Ebata T, Igami T, Matsushita M, Nishikimi N, Kamei Y. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg 2010;252(1):115-123.PubMedCrossRef Nagino M, Nimura Y, Nishio H, Ebata T, Igami T, Matsushita M, Nishikimi N, Kamei Y. Hepatectomy with simultaneous resection of the portal vein and hepatic artery for advanced perihilar cholangiocarcinoma: an audit of 50 consecutive cases. Ann Surg 2010;252(1):115-123.PubMedCrossRef
8.
go back to reference Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otuka M, Kato A, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Suda K, Takano S. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci 2010;17(4):470-475.PubMedCrossRef Miyazaki M, Kimura F, Shimizu H, Yoshidome H, Otuka M, Kato A, Yoshitomi H, Furukawa K, Takeuchi D, Takayashiki T, Suda K, Takano S. One hundred seven consecutive surgical resections for hilar cholangiocarcinoma of Bismuth types II, III, IV between 2001 and 2008. J Hepatobiliary Pancreat Sci 2010;17(4):470-475.PubMedCrossRef
9.
go back to reference Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Miyazaki M. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg 2010;251(2):281-286.PubMedCrossRef Shimizu H, Kimura F, Yoshidome H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Miyazaki M. Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy. Ann Surg 2010;251(2):281-286.PubMedCrossRef
10.
go back to reference Grandadam S, Compagnon P, Arnaud A, Olivie D, Malledant Y, Meunier B, Launois B, Boudjema K. Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III. Ann Surg Oncol 2010;17(12):3155-3161.PubMedCrossRef Grandadam S, Compagnon P, Arnaud A, Olivie D, Malledant Y, Meunier B, Launois B, Boudjema K. Role of preoperative optimization of the liver for resection in patients with hilar cholangiocarcinoma type III. Ann Surg Oncol 2010;17(12):3155-3161.PubMedCrossRef
11.
go back to reference Hemming AW, Kim RD, Mekeel KL, Fujita S, Reed AI, Foley DP, Howard RJ. Portal vein resection for hilar cholangiocarcinoma. Am Surg 2006;72(7):599-604; discussion 604-5.PubMed Hemming AW, Kim RD, Mekeel KL, Fujita S, Reed AI, Foley DP, Howard RJ. Portal vein resection for hilar cholangiocarcinoma. Am Surg 2006;72(7):599-604; discussion 604-5.PubMed
12.
go back to reference Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB, Gores GJ. Transplantation for hilar cholangiocarcinoma. Liver Transpl 2004;10(10 Suppl 2):S65-8.PubMedCrossRef Heimbach JK, Haddock MG, Alberts SR, Nyberg SL, Ishitani MB, Rosen CB, Gores GJ. Transplantation for hilar cholangiocarcinoma. Liver Transpl 2004;10(10 Suppl 2):S65-8.PubMedCrossRef
13.
go back to reference Choti MA, Bowman HM, Pitt HA, Sosa JA, Sitzmann JV, Cameron JL, Gordon TA. Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg 1998;2(1):11-20.PubMedCrossRef Choti MA, Bowman HM, Pitt HA, Sosa JA, Sitzmann JV, Cameron JL, Gordon TA. Should hepatic resections be performed at high-volume referral centers? J Gastrointest Surg 1998;2(1):11-20.PubMedCrossRef
14.
go back to reference Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg 1999;134(1):30-35.PubMedCrossRef Glasgow RE, Showstack JA, Katz PP, Corvera CU, Warren RS, Mulvihill SJ. The relationship between hospital volume and outcomes of hepatic resection for hepatocellular carcinoma. Arch Surg 1999;134(1):30-35.PubMedCrossRef
15.
go back to reference Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 1995;221(1):43-49.PubMedCrossRef Gordon TA, Burleyson GP, Tielsch JM, Cameron JL. The effects of regionalization on cost and outcome for one general high-risk surgical procedure. Ann Surg 1995;221(1):43-49.PubMedCrossRef
16.
go back to reference Gordon TA, Bowman HM, Tielsch JM, Bass EB, Burleyson GP, Cameron JL. Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg 1998;228(1):71-78.PubMedCrossRef Gordon TA, Bowman HM, Tielsch JM, Bass EB, Burleyson GP, Cameron JL. Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality. Ann Surg 1998;228(1):71-78.PubMedCrossRef
17.
go back to reference Gordon TA, Bowman HM, Bass EB, Lillemoe KD, Yeo CJ, Heitmiller RF, Choti MA, Burleyson GP, Hsieh G, Cameron JL. Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes. J Am Coll Surg 1999;189(1):46-56.PubMedCrossRef Gordon TA, Bowman HM, Bass EB, Lillemoe KD, Yeo CJ, Heitmiller RF, Choti MA, Burleyson GP, Hsieh G, Cameron JL. Complex gastrointestinal surgery: impact of provider experience on clinical and economic outcomes. J Am Coll Surg 1999;189(1):46-56.PubMedCrossRef
18.
go back to reference Hollenbeck BK, Dunn RL, Miller DC, Daignault S, Taub DA, Wei JT. Volume-based referral for cancer surgery: informing the debate. J Clin Oncol 2007;25(1):91-96.PubMedCrossRef Hollenbeck BK, Dunn RL, Miller DC, Daignault S, Taub DA, Wei JT. Volume-based referral for cancer surgery: informing the debate. J Clin Oncol 2007;25(1):91-96.PubMedCrossRef
20.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383.PubMedCrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40(5):373-383.PubMedCrossRef
21.
go back to reference Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46(10):1075-9; discussion 1081-90.PubMedCrossRef Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives. J Clin Epidemiol 1993;46(10):1075-9; discussion 1081-90.PubMedCrossRef
22.
go back to reference Hemming AW, Reed AI, Fujita S, Zendejas I, Howard RJ, Kim RD. Role for extending hepatic resection using an aggressive approach to liver surgery. J Am Coll Surg 2008;206(5):870-5; discussion 875-8.PubMedCrossRef Hemming AW, Reed AI, Fujita S, Zendejas I, Howard RJ, Kim RD. Role for extending hepatic resection using an aggressive approach to liver surgery. J Am Coll Surg 2008;206(5):870-5; discussion 875-8.PubMedCrossRef
23.
go back to reference Schiffman SC, Reuter NP, McMasters KM, Scoggins CR, Martin RC. Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol 2012;105(1):91-96.PubMedCrossRef Schiffman SC, Reuter NP, McMasters KM, Scoggins CR, Martin RC. Overall survival peri-hilar cholangiocarcinoma: R1 resection with curative intent compared to primary endoscopic therapy. J Surg Oncol 2012;105(1):91-96.PubMedCrossRef
24.
go back to reference Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Hawkins IF, Vauthey JN. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003;237(5):686-91; discussion 691-3.PubMed Hemming AW, Reed AI, Howard RJ, Fujita S, Hochwald SN, Caridi JG, Hawkins IF, Vauthey JN. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003;237(5):686-91; discussion 691-3.PubMed
25.
go back to reference Hemming AW, Magliocca JF, Fujita S, Kayler LK, Hochwald S, Zendejas I, Kim RD. Combined resection of the liver and pancreas for malignancy. J Am Coll Surg 2010;210(5):808-14, 814-6.PubMedCrossRef Hemming AW, Magliocca JF, Fujita S, Kayler LK, Hochwald S, Zendejas I, Kim RD. Combined resection of the liver and pancreas for malignancy. J Am Coll Surg 2010;210(5):808-14, 814-6.PubMedCrossRef
26.
go back to reference Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011;2(2):94-107.PubMedCrossRef Akamatsu N, Sugawara Y, Hashimoto D. Surgical strategy for bile duct cancer: Advances and current limitations. World J Clin Oncol 2011;2(2):94-107.PubMedCrossRef
27.
go back to reference Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 2005;242(4):540-4; discussion 544-7.PubMed Fong Y, Gonen M, Rubin D, Radzyner M, Brennan MF. Long-term survival is superior after resection for cancer in high-volume centers. Ann Surg 2005;242(4):540-4; discussion 544-7.PubMed
28.
go back to reference Dimick JB, Wainess RM, Cowan JA, Upchurch GR,Jr, Knol JA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 2004;199(1):31-38.PubMedCrossRef Dimick JB, Wainess RM, Cowan JA, Upchurch GR,Jr, Knol JA, Colletti LM. National trends in the use and outcomes of hepatic resection. J Am Coll Surg 2004;199(1):31-38.PubMedCrossRef
Metadata
Title
Surgical Management Trends for Cholangiocarcinoma in the USA 1998–2009
Authors
Jamie E. Anderson
Alan W. Hemming
David C. Chang
Mark A. Talamini
Kristin L. Mekeel
Publication date
01-12-2012
Publisher
Springer-Verlag
Published in
Journal of Gastrointestinal Surgery / Issue 12/2012
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI
https://doi.org/10.1007/s11605-012-1980-9

Other articles of this Issue 12/2012

Journal of Gastrointestinal Surgery 12/2012 Go to the issue